Literature DB >> 24859660

Transcranial cavitation detection in primates during blood-brain barrier opening--a performance assessment study.

Shih-Ying Wu, Yao-Sheng Tung, Fabrice Marquet, Matthew Downs, Carlos Sanchez, Cherry Chen, Vincent Ferrera, Elisa Konofagou.   

Abstract

Focused ultrasound (FUS) has been shown promise in treating the brain locally and noninvasively. Transcranial passive cavitation detection (PCD) provides methodology for monitoring the treatment in real time, but the skull effects remain a major challenge for its translation to the clinic. In this study, we investigated the sensitivity, reliability, and limitations of PCD through primate (macaque and human) skulls in vitro. The results were further correlated with the in vivo macaque studies including the transcranial PCD calibration and real-time monitoring of blood-brain barrier (BBB) opening, with magnetic resonance imaging assessing the opening and safety. The stable cavitation doses using harmonics (SCDh) and ultraharmonics (SCDu), the inertial cavitation dose (ICD), and the cavitation SNR were quantified based on the PCD signals. Results showed that through the macaque skull, the pressure threshold for detecting the SCDh remained the same as without the skull in place, whereas it increased for the SCDu and ICD; through the human skull, it increased for all cavitation doses. The transcranial PCD was found to be reliable both in vitro and in vivo when the transcranial cavitation SNR exceeded the 1-dB detection limit through the in vitro macaque (attenuation: 4.92 dB/mm) and human (attenuation: 7.33 dB/ mm) skull. In addition, using long pulses enabled reliable PCD monitoring and facilitate BBB opening at low pressures. The in vivo results showed that the SCDh became detectable at pressures as low as 100 kPa; the ICD became detectable at 250 kPa, although it could occur at lower pressures; and the SCDu became detectable at 700 kPa and was less reliable at lower pressures. Real-time monitoring of PCD was further implemented during BBB opening, with successful and safe opening achieved at 250 to 600 kPa in both the thalamus and the putamen. In conclusion, this study shows that transcranial PCD in macaques in vitro and in vivo, and in humans in vitro, is reliable by improving the cavitation SNR beyond the 1-dB detection limit.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24859660      PMCID: PMC4034133          DOI: 10.1109/TUFFC.2014.2992

Source DB:  PubMed          Journal:  IEEE Trans Ultrason Ferroelectr Freq Control        ISSN: 0885-3010            Impact factor:   2.725


  42 in total

1.  Thresholds for inertial cavitation in albunex suspensions under pulsed ultrasound conditions.

Authors:  P P Chang; W S Chen; P D Mourad; S L Poliachik; L A Crum
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2001-01       Impact factor: 2.725

Review 2.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

3.  Ultrasonic contrast agent shell rupture detected by inertial cavitation and rebound signals.

Authors:  Azzdine Y Ammi; Robin O Cleveland; Jonathan Mamou; Grace I Wang; S Lori Bridal; William D O'Brien
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2006-01       Impact factor: 2.725

4.  Non-invasive transcranial ultrasound therapy based on a 3D CT scan: protocol validation and in vitro results.

Authors:  F Marquet; M Pernot; J-F Aubry; G Montaldo; L Marsac; M Tanter; M Fink
Journal:  Phys Med Biol       Date:  2009-04-08       Impact factor: 3.609

5.  A super-resolution ultrasound method for brain vascular mapping.

Authors:  Meaghan A O'Reilly; Kullervo Hynynen
Journal:  Med Phys       Date:  2013-11       Impact factor: 4.071

6.  FEASIBILITY STUDY OF A CLINICAL BLOOD-BRAIN BARRIER OPENING ULTRASOUND SYSTEM.

Authors:  Fabrice Marquet; Yao-Sheng Tung; Elisa E Konofagou
Journal:  Nano Life       Date:  2010-09

7.  Acoustical properties of the human skull.

Authors:  F J Fry; J E Barger
Journal:  J Acoust Soc Am       Date:  1978-05       Impact factor: 1.840

8.  Identifying the inertial cavitation threshold and skull effects in a vessel phantom using focused ultrasound and microbubbles.

Authors:  Yao-Sheng Tung; James J Choi; Babak Baseri; Elisa E Konofagou
Journal:  Ultrasound Med Biol       Date:  2010-05       Impact factor: 2.998

9.  Transcranial magnetic resonance imaging- guided focused ultrasound surgery of brain tumors: initial findings in 3 patients.

Authors:  Nathan McDannold; Greg T Clement; Peter Black; Ferenc Jolesz; Kullervo Hynynen
Journal:  Neurosurgery       Date:  2010-02       Impact factor: 4.654

10.  A pilot study of focused ultrasound thalamotomy for essential tremor.

Authors:  W Jeffrey Elias; Diane Huss; Tiffini Voss; Johanna Loomba; Mohamad Khaled; Eyal Zadicario; Robert C Frysinger; Scott A Sperling; Scott Wylie; Stephen J Monteith; Jason Druzgal; Binit B Shah; Madaline Harrison; Max Wintermark
Journal:  N Engl J Med       Date:  2013-08-15       Impact factor: 91.245

View more
  38 in total

Review 1.  Focused ultrasound-mediated drug delivery through the blood-brain barrier.

Authors:  Alison Burgess; Kairavi Shah; Olivia Hough; Kullervo Hynynen
Journal:  Expert Rev Neurother       Date:  2015-05       Impact factor: 4.618

2.  Lipid microbubbles as a vehicle for targeted drug delivery using focused ultrasound-induced blood-brain barrier opening.

Authors:  Carlos Sierra; Camilo Acosta; Cherry Chen; Shih-Ying Wu; Maria E Karakatsani; Manuel Bernal; Elisa E Konofagou
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

3.  Experimental demonstration of passive acoustic imaging in the human skull cavity using CT-based aberration corrections.

Authors:  Ryan M Jones; Meaghan A O'Reilly; Kullervo Hynynen
Journal:  Med Phys       Date:  2015-07       Impact factor: 4.071

4.  Pulse inversion enhances the passive mapping of microbubble-based ultrasound therapy.

Authors:  Antonios N Pouliopoulos; Mark T Burgess; Elisa E Konofagou
Journal:  Appl Phys Lett       Date:  2018-07-24       Impact factor: 3.791

5.  Effects of the microbubble shell physicochemical properties on ultrasound-mediated drug delivery to the brain.

Authors:  Shih-Ying Wu; Cherry C Chen; Yao-Sheng Tung; Oluyemi O Olumolade; Elisa E Konofagou
Journal:  J Control Release       Date:  2015-06-09       Impact factor: 9.776

6.  Chirp- and random-based coded ultrasonic excitation for localized blood-brain barrier opening.

Authors:  H A S Kamimura; S Wang; S-Y Wu; M E Karakatsani; C Acosta; A A O Carneiro; E E Konofagou
Journal:  Phys Med Biol       Date:  2015-10-07       Impact factor: 3.609

7.  Feedback control of microbubble cavitation for ultrasound-mediated blood-brain barrier disruption in non-human primates under magnetic resonance guidance.

Authors:  Hermes As Kamimura; Julien Flament; Julien Valette; Andrea Cafarelli; Romina Aron Badin; Philippe Hantraye; Benoît Larrat
Journal:  J Cereb Blood Flow Metab       Date:  2018-01-30       Impact factor: 6.200

Review 8.  Ultrasound treatment of neurological diseases--current and emerging applications.

Authors:  Gerhard Leinenga; Christian Langton; Rebecca Nisbet; Jürgen Götz
Journal:  Nat Rev Neurol       Date:  2016-02-19       Impact factor: 42.937

9.  The partitioning of nanoparticles to endothelium or interstitium during ultrasound-microbubble-targeted delivery depends on peak-negative pressure.

Authors:  Y-H Hsiang; J Song; R J Price
Journal:  J Nanopart Res       Date:  2015-08-22       Impact factor: 2.253

Review 10.  Drug and gene delivery across the blood-brain barrier with focused ultrasound.

Authors:  Kelsie F Timbie; Brian P Mead; Richard J Price
Journal:  J Control Release       Date:  2015-09-08       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.